Summary
GBI Research, the leading business intelligence provider, has released its latest research "The Future of Respiratory Diseases Therapeutics-Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis." The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global respiratory diseases therapeutics market. The report analyzes the markets for respiratory disease therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2015 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.
Scope
The scope of this report includes:
-Annualized market data for the respiratory diseases therapeutics market from 2000 to 2008, forecast forward to 2015
-Analysis of the leading therapeutic segments including asthma, chronic obstructive pulmonary disease (COPD), pulmonary hypertension and cystic fibrosis
-Analysis of the respiratory diseases therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan
-Market characterization of the respiratory diseases therapeutics market including market size, annual cost of therapy, sales volume and treatment usage patterns
-Key drivers and barriers that have a significant impact on the market
-Coverage of pipeline molecules in various phases of drug development
-Competitive benchmarking of leading companies. The key companies studied in this report are Novartis AG, AstraZeneca and Merck & Co
-Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global respiratory diseases therapeutics market
Reasons to buy
The report will enhance your decision making capability. It will allow you to
-Align product portfolio to the markets with high growth potential
-Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth
-Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety
-Develop key strategic initiatives by understanding key focus areas of leading companies
-Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps
Table of Contents
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 9
2 Global Respiratory Therapeutics Market: Scope of Research 11
2.1 Introduction 11
2.2 GBI Research Report Guidance 11
3 Global Respiratory Therapeutics Market: Market Characteraization 12
3.1 Market Forecasts 12
3.2 Branded Vs Generics 13
3.3 Average Cost of Therapy 14
3.4 Volume 15
3.5 Usage Patterns 16
3.5.1 Diseased Population 16
3.5.2 Treatment Seeking Population 17
3.5.3 Diagnosed Population 18
3.5.4 Prescription Population 19
3.5.5 Usage Patterns 20
3.5.6 Global Revenue Distribution Indication Wise 22
4 Global Asthma Therapeutics Market 23
4.1 Market Forecasts 23
4.2 Average Cost of Therapy 24
4.3 Volume 25
4.4 Usage Patterns 26
4.4.1 Diseased Population 26
4.4.2 Treatment Seeking Population 27
4.4.3 Diagnosed Population 28
4.4.4 Prescription Population 28
4.4.5 Usage Patterns 29
5 Global COPD Therapeutics Market 31
5.1 Market Forecasts 31
5.2 Average Cost of Therapy 32
5.3 Volume 32
5.4 Usage Patterns 34
5.4.1 Diseased Population 34
5.4.2 Treatment Seeking Population 35
5.4.3 Diagnosed Population 36
5.4.4 Prescription Population 37
5.4.5 Usage Patterns 37
6 Global Pulmonary Arterial Hypertension Therapeutics Market 39
6.1 Market Forecasts 39
6.2 Volume 40
6.3 Average Cost of Therapy 41
6.4 Usage Patterns 42
6.4.1 Diseased Population 42
6.4.2 Treatment Seeking Population 43
6.4.3 Diagnosed Population 44
6.4.4 Prescription Population 45
6.4.5 Usage Patterns 45
7 Global Cystic Fibrosis Therapeutics Market 47
7.1 Market Forecasts 47
7.2 Volume 48
7.3 Average Cost of Therapy 49
7.4 Usage Patterns 50
7.4.1 Diseased Population 50
7.4.2 Treatment Seeking Population 51
7.4.3 Diagnosed Population 52
7.4.4 Prescription Population 53
7.4.5 Usage Patterns 53
8 Global Respiratory Therapeutics Market: Market Drivers and Restraints 55
8.1 Market Drivers 55
8.1.1 Steady Increase in the Smoking Population 55
8.1.2 Stable Increase in Incidence Rates for Respiratory Diseases Disorders 56
8.1.3 Increase in Awareness Levels of Disease Progression and Etiology 56
8.2 Market Restraints 56
8.2.1 Patent Expirations and Entry of Generics Pose a Serious Problem for Primary Manufacturers 56
8.2.2 Reimbursement Restrictions on Drug Classes for Certain Respiratory Diseases Drug Classes Restricts the Market Growth 57
8.3 Global Respiratory Therapeutics Market: Unmet Needs 57
8.4 Global Respiratory Therapeutics Market: Key Market Trends 58
8.5 Increase in Disease Incidence and Prevalence Rates 59
8.6 Product Pipeline 59
8.7 Advertising and Commercialization 59
8.8 Regulatory Trends-Current Reimbursement Scenario 59
8.8.1 The Budget Impact on Drug Reimbursements 60
8.8.2 Reliability on Generic Formulations as a Cost Cutting Measure 60
9 Global Respiratory Therapeutics Market: Competitive Landscape 61
9.1 Overview 61
9.2 Market Share Analysis 61
9.3 Competitive Profiling 62
9.3.1 GlaxoSmithKline 63
9.3.2 AstraZeneca 63
9.3.3 Merck 63
9.3.4 Boehringer Ingelheim GmbH 64
10 Global Respiratory Therapeutics Market: Strategic Consolidations 65
10.1 Mergers and Acquisitions 65
10.1.1 Overview 65
10.2 Licensing Agreements 67
10.2.1 Approval 69
10.2.2 Filed 70
10.2.3 Phase III 70
10.2.4 Phase II 71
10.2.5 Pre-clinical 72
10.2.6 Discovery 72
11 Global Respiratory Therapeutics Market: Appendix 73
11.1 Market Definitions 73
11.2 Abbreviations 73
11.3 Research Methodology 74
11.3.1 Coverage 74
11.3.2 Primary Research 77
11.3.3 Expert Panels 78
11.4 Contact Us 78
11.5 Disclaimer 78
List of Tables
1.1 List of Tables
Table 1: Global Respiratory Therapeutics Market, Historical Revenues ($m), 2000-2008 12
Table 2: Global Respiratory Therapeutics Market, Revenue Forecasts ($m), 2008-2015 12
Table 3: Global Respiratory Therapeutics Market, Revenue ($bn) Segmentation, 2000-2008 13
Table 4: Global Respiratory Therapeutics Market, Revenue ($bn) Segmentation, 2008-2015 14
Table 5: Global Respiratory Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008 14
Table 6: Global Respiratory Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015 15
Table 7: Global Respiratory Therapeutics Market, Historical Figures for Volume, 2000-2008 15
Table 8: Global Respiratory Therapeutics Market, Forecasts for Volume, 2008-2015 16
Table 9: Global Respiratory Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 17
Table 10: Global Respiratory Therapeutics Market, Forecasts for Diseased Population,
2008-2015 17
Table 11: Global Respiratory Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 18
Table 12: Global Respiratory Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 18
Table 13: Global Respiratory Therapeutics Market, Historical Figures for Diagnosed Population, 2000-2008 19
Table 14: Global Respiratory Therapeutics Market, Forecasts for Diagnosed Population,
2008-2015 19
Table 15: Global Respiratory Therapeutics Market, Historical Figures for Prescription Population, 2000-2008, 20
Table 16: Global Respiratory Therapeutics Market, Forecasts for Prescription Population,
2008-2015 20
Table 17: Global Respiratory Therapeutics Market, Historical Figures for Usage Patterns,
2000-2008 21
Table 18: Global Respiratory Therapeutics Market, Forecasts for Usage Patterns, 2008-2015 21
Table 19: Global Asthma Therapeutics Market, Historical Revenues ($bn), 2000-2008 23
Table 20: Global Asthma Therapeutics Market, Revenue Forecasts ($bn), 2008-2015 23
Table 21: Global Asthma Therapeutics Market, Historical Figures for the Average Cost of Therapy ($), 2000-2008 24
Table 22: Global Asthma Therapeutics Market, Forecast Figures for the Average Cost of Therapy ($), 2008-2015 24
Table 23: Global Asthma Therapeutics Market, Historical Figures for Volume, 2000-2008 25
Table 24: Global Asthma Therapeutics Market, Forecasts for Volume, 2008-2015 25
Table 25: Global Asthma Therapeutics Market, Historical Figures for Diseased Population,
2000-2008 26
Table 26: Global Asthma Therapeutics Market, Forecasts for Diseased Population, 2008-2015 26
Table 27: Global Asthma Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 27
Table 28: Global Asthma Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 27
Table 29: Global Asthma Therapeutics Market, Historical Figures for Diagnosed Population, 2000-2008 28
Table 30: Global Asthma Therapeutics Market, Forecasts for Diagnosed Population, 2008-2015 28
Table 31: Global Asthma Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 29
Table 32: Global Asthma Therapeutics Market, Forecasts for Prescription Population, 2008-2015 29
Table 33: Global Asthma Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 30
Table 34: Global Asthma Therapeutics Market, Forecasts for Usage Patterns, 2008-2015 30
Table 35: Global COPD Therapeutics Market, Historical Revenues ($m), 2000-2008 31
Table 36: Global COPD Therapeutics Market, Revenue Forecasts ($m), 2008-2015 31
Table 37: Global COPD Therapeutics Market, Historical Figures for the Average Cost of Therapy ($), 2000-2008 32
Table 38: Global COPD Therapeutics Market, Forecast Figures for the Average Cost of Therapy ($), 2008-2015 32
Table 39: Global COPD Therapeutics Market, Historical Figures for Volume, 2000-2008 33
Table 40: Global COPD Therapeutics Market, Forecasts for Volume, 2008-2015 33
Table 41: Global COPD Therapeutics Market, Historical Figures for Diseased Population,
2000-2008 34
Table 42: Global COPD Therapeutics Market, Forecasts for Diseased Population, 2008-2015 34
Table 43: Global COPD Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 35
Table 44: Global COPD Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 35
Table 45: Global COPD Therapeutics Market, Historical Figures for Diagnosed Population,
2000-2008 36
Table 46: Global COPD Therapeutics Market, Forecasts for Diagnosed Population, 2008-2015 36
Table 47: Global COPD Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 37
Table 48: Global COPD Therapeutics Market, Forecasts for Prescription Population, 2008-2015 37
Table 49: Global COPD Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 38
Table 50: Global COPD Therapeutics Market, Forecasts for Usage Patterns, 2008-2015 38
Table 51: Global Pulmonary Hypertension Therapeutics Market, Historical Revenues ($m),
2000-2008 39
Table 52: Global Pulmonary Hypertension Therapeutics Market, Revenue Forecasts ($m),
2008-2015 39
Table 53: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Volume, 2000-2008 40
Table 54: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Volume,
2008-2015 40
Table 55: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008 41
Table 56: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015 41
Table 57: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 42
Table 58: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Diseased Population, 2008-2015 42
Table 59: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 43
Table 60: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 43
Table 61: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Diagnosed Population, 2000-2008 44
Table 62: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Diagnosed Population, 2008-2015 44
Table 63: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 45
Table 64: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Prescription Population, 2008-2015 45
Table 65: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 46
Table 66: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Usage Patterns, 2008-2015 46
Table 67: Global Cystic Fibrosis Therapeutics Market, Historical Revenues ($m), 2000-2008 47
Table 68: Global Cystic Fibrosis Therapeutics Market, Revenue Forecasts ($m), 2008-2015 47
Table 69: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Volume, 2000-2008 48
Table 70: Global Cystic Fibrosis Therapeutics Market, Forecasts for Volume, 2008-2015 48
Table 71: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008 49
Table 72: Global Cystic Fibrosis Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015 49
Table 73: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 50
Table 74: Global Cystic Fibrosis Therapeutics Market, Forecasts for Diseased Population,
2008-2015 50
Table 75: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 51
Table 76: Global Cystic Fibrosis Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 51
Table 77: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Diagnosed Population, 2000-2008 52
Table 78: Global Cystic Fibrosis Therapeutics Market, Forecasts for Diagnosed Population,
2008-2015 52
Table 79: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 53
Table 80: Global Cystic Fibrosis Therapeutics Market, Forecasts for Prescription Population, 2008-2015 53
Table 81: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 54
Table 82: Global Cystic Fibrosis Therapeutics Market, Forecasts for Usage Patterns, 2008-2015 54
Table 83: Global Respiratory Therapeutics Market, Market Drivers, 2008 55
Table 84: Global Respiratory Therapeutics Market, Market Restraints, 2008 56
Table 85: Global Respiratory Therapeutics Market, Major Drug Patent Expirations, 2008-2015 57
Table 86: Global Respiratory Therapeutics Market, Licensing Agreements for Approved Drugs, 2008-2009 69
Table 87: Global Respiratory Therapeutics Market, Licensing Agreements for Drugs in the NDA/BLA Filed Stage, 2008-2009 70
Table 88: Global Respiratory Therapeutics Market, Licensing Agreements for Drugs in the Phase III Stage, 2008-2009 71
Table 89: Global Respiratory Therapeutics Market, Licensing Agreements for Drugs in the Phase II Stage, 2008-2009 71
Table 90: Global Respiratory Therapeutics Market, Licensing Agreements for Drugs in the Pre-Clinical Stage, 2008-2009 72
Table 91: Global Respiratory Therapeutics Market, Licensing Agreements for Drugs in the Discovery Stage, 2008-2009 72
List of Figures
1.2 List of Figures
Figure 1: Global Respiratory Therapeutics Market, Revenue Forecasts ($m), 2000-2015 12
Figure 2: Global Respiratory Therapeutics Market, Revenue Segmentation, 2000-2015 13
Figure 3: Global Respiratory Therapeutics Market, Average Cost of Therapy ($), 2000-2015 14
Figure 4: Global Respiratory Therapeutics Market, Volume, 2000-2015 15
Figure 5: Global Respiratory Therapeutics Market, Diseased Population, 2000-2015 16
Figure 6: Global Respiratory Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 17
Figure 7: Global Respiratory Therapeutics Market, Global Forecasts for Diagnosed Population, 2000-2015 19
Figure 8: Global Respiratory Therapeutics Market, Forecasts for Prescription Population,
2000-2015 20
Figure 9: Global Respiratory Therapeutics Market, Forecasts for Usage Patterns, 2000-2015 21
Figure 10: Global Respiratory Therapeutics Market, Revenue Distribution Indication Wise ($m), 2000-2015 22
Figure 11: Global Asthma Therapeutics Market, Revenue Forecasts ($m), 2000-2015 23
Figure 12: Global Asthma Therapeutics Market, Average Cost of Therapy ($), 2000-2015 24
Figure 13: Global Asthma Therapeutics Market, Volume, 2000-2015 25
Figure 14: Global Asthma Therapeutics Market, Forecasts for Diseased Population, 2000-2015 26
Figure 15: Global Asthma Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 27
Figure 16: Global Asthma Therapeutics Market, Forecasts for Diagnosed Population, 2000-2015 28
Figure 17: Global Asthma Therapeutics Market, Forecasts for Prescription Population, 2000-2015 29
Figure 18: Global Asthma Therapeutics Market, Forecasts for Usage Patterns, 2000-2015 30
Figure 19: Global COPD Therapeutics Market, Revenue Forecasts ($m), 2000-2015 31
Figure 20: Global COPD Therapeutics Market, Average Cost of Therapy ($), 2000-2015 32
Figure 21: Global COPD Therapeutics Market, Volume, 2000-2015 33
Figure 22: Global COPD Therapeutics Market, Forecasts for Diseased Population, 2000-2015 34
Figure 23: Global COPD Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 35
Figure 24: Global COPD Therapeutics Market, Forecasts for Diagnosed Population, 2000-2015 36
Figure 25: Global COPD Therapeutics Market, Forecasts for Prescription Population, 2000-2015 37
Figure 26: Global COPD Therapeutics Market, Forecasts for Usage Patterns, 2000-2015 38
Figure 27: Global Pulmonary Hypertension Therapeutics Market, Revenue Forecasts ($m),
2000-2015 39
Figure 28: Global Pulmonary Hypertension Therapeutics Market, Volume, 2000-2015 40
Figure 29: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2000-2015 41
Figure 30: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Diseased Population, 2000-2015 42
Figure 31: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 43
Figure 32: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Diagnosed Population, 2000-2015 44
Figure 33: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Prescription Population, 2000-2015 45
Figure 34: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Usage Patterns, 2000-2015 46
Figure 35: Global Cystic Fibrosis Therapeutics Market, Revenue Forecasts ($m), 2000-2015 47
Figure 36: Global Cystic Fibrosis Therapeutics Market, Volume, 2000-2015 48
Figure 37: Global Cystic Fibrosis Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2000-2015 49
Figure 38: Global Cystic Fibrosis Therapeutics Market, Forecasts for Diseased Population,
2000-2015 50
Figure 39: Global Cystic Fibrosis Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 51
Figure 40: Global Cystic Fibrosis Therapeutics Market, Forecasts for Diagnosed Population,
2000-2015 52
Figure 41: Global Cystic Fibrosis Therapeutics Market, Forecasts for Prescription Population, 2000-2015 53
Figure 42: Global Cystic Fibrosis Therapeutics Market, Forecasts for Usage Patterns, 2000-2015 54
Figure 43: Global Respiratory Therapeutics Market, Market Indicators, 2008 55
Figure 44: Global Respiratory Therapeutics Market, Analysis of Unmet Needs for Major Disease Sectors, 2008 58
Figure 45: Global Respiratory Therapeutics Market, Key Market Events, 2008-2015 58
Figure 46: Global Respiratory Therapeutics Market, Market Share of Top Manufacturers, 2008 61
Figure 47: Respiratory Therapeutics Market, Global Benchmarking Analysis for the Top Four Manufacturers, 2008 62
Figure 48: Respiratory Therapeutics Market, Global Benchmarking Analysis for the Top Four Manufacturers, Pipeline and Unmet Need Analysis, 2008 63
Figure 49: Global Respiratory Therapeutics Market, M&A Deals by Geography, 2008 65
Figure 50: Global Respiratory Therapeutics Market, M&A Deals by Deal Size, 2008 65
Figure 51: Global Respiratory Therapeutics Market, M&A Deals by Phase, 2008 66
Figure 52: Global Respiratory Therapeutics Market, Top Three M&A Deals, 2008 66
Figure 53: Global Respiratory Therapeutics Market, Licensing Agreements by Geography, 2008 67
Figure 54: Global Respiratory Therapeutics Market, Licensing Agreements by Deal Size, 2008 68
Figure 55: Global Respiratory Therapeutics Market, Licensing Agreements by Phases of Development, 2008 68
Figure 56: Global Respiratory Therapeutics Market, Licensing Agreements by Indications, 2008 69
Figure 57: GBI Research Methodology 74
Figure 58: GBI Research Market Forecasting Model 77
